• Tris Pharma® Acquires Park Therapeutics americanpharmaceuticalreview
    April 30, 2021
    Tris Pharma, Inc., a specialty pharmaceutical company with a portfolio of approved products and a late-stage pipeline of product candidates for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) and related conditions, has acquired Park ...
PharmaSources Customer Service